Alternate Measures of Glucose During OGTT Testing for CFRD
NCT ID: NCT05568134
Last Updated: 2025-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2023-07-17
2024-12-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cystic Fibrosis Related Diabetes Screening.
NCT02723968
Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT
NCT01883037
Oral Glucose Tolerance Testing Using Candy for Cystic Fibrosis
NCT04579939
Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes
NCT05505565
Continuous Glucose Monitoring (CGM) in an Underserved Population
NCT07135531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OGTT Cohort
All enrolled participants will complete an OGTT.
Oral glucose tolerance test
An oral glucose tolerance test will be completed. A fasting glucose will be measured.
Participants will drink 1.75 g/kg of dextrose (up to a maximum of 75 grams) within 10 minutes. Glucose values will be measured at 1 hour and 2 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral glucose tolerance test
An oral glucose tolerance test will be completed. A fasting glucose will be measured.
Participants will drink 1.75 g/kg of dextrose (up to a maximum of 75 grams) within 10 minutes. Glucose values will be measured at 1 hour and 2 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥ 10 years of age
* Fluency in written and spoken English as the GTT@Home is currently only available in English
Exclusion Criteria
* Major medical or psychiatric disorders other than CF
* Use of medications known to impact the accuracy of the Dexcom G7 (hydroxyurea, \>2g acetaminophen per day)
* History of severe adhesive reactions that may lead to an inability to tolerate CGM wear
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cystic Fibrosis Foundation
OTHER
Children's Hospital of Philadelphia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-020249
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.